Gaia Giribaldi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Gaia Giribaldi has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Andrea Rossi
Neuroradiology Unit IRCCS Istituto Giannina Gaslini Genoa Italy
1 shared publication Claudio Bruno
Neuromuscular Diseases Unit, G. Gaslini Institute, Genoa, Italy
1 shared publicationCristina Schiaffino
Paediatric Clinic, University of Genoa, G. Gaslini Institute, Genoa
1 shared publication- Filippo Maria Santorelli
Department of Developmental Neuroscience, IRCCS Fondazione Stella Maris, 56128 Pisa, Italy
1 shared publication - Fiorella Piemonte
Unit of Muscular and Neurodegenerative Diseases, Bambino Gesù Children’s Hospital, IRCCS, Rome, Italy
1 shared publication Laura Doria‐Lamba
Department of Neuroscience, Ophthalmology and Genetics, Child Neuropsychiatry Unit, G. Gaslini Institute, and University of Genoa, Genoa
1 shared publication
Latest Publications
- 5 December 2011
- Published by Wiley in Developmental Medicine & Child Neurology
- Vol. 54 (5) , 472-476
Intermittent‐relapsing pyruvate dehydrogenase complex deficiency: a case with clinical, biochemical, and neuroradiological reversibility
Pyruvate dehydrogenase complex (PDHC) deficiency causes encephalomyopathies, of which there are four major categories: (1) neonatal encephalopathy with lactic acidosis; (2) an early infantile form, which (3) at times resembles Leigh syndrome; and (4) a later‐onset form. Long‐term clinical and radiological follow‐up is still incompletely elucidated. We report a 12‐year‐old male with intermittent‐relapsing PDHC deficiency who presented with three typical acute episodes of metabolic decompensation over 7 years. Neuroimaging showed reversible signal abnormalities in the basal ganglia, inferior olivary nuclei, periaqueductal grey matter, and dentate nuclei, with evidence of lactate on magnetic resonance spectroscopy. Molecular analysis of PDH1A revealed a novel hemizygous c.1045G>A mutation, predicting a p.A349T missense mutation. He was treated with thiamine supplementation and, while on this regimen, he experienced several intercurrent febrile episodes without neurological compromise. This case report stresses the importance of performing neuroimaging during acute clinical episodes because brain lesions in PDHC deficiency may be transient and reversible, and false‐negative results may mislead the diagnosis and delay the treatment.
- 5 December 2011
- Published by Wiley in Developmental Medicine & Child Neurology
- Vol. 54 (5) , 472-476
Intermittent‐relapsing pyruvate dehydrogenase complex deficiency: a case with clinical, biochemical, and neuroradiological reversibility
Pyruvate dehydrogenase complex (PDHC) deficiency causes encephalomyopathies, of which there are four major categories: (1) neonatal encephalopathy with lactic acidosis; (2) an early infantile form, which (3) at times resembles Leigh syndrome; and (4) a later‐onset form. Long‐term clinical and radiological follow‐up is still incompletely elucidated. We report a 12‐year‐old male with intermittent‐relapsing PDHC deficiency who presented with three typical acute episodes of metabolic decompensation over 7 years. Neuroimaging showed reversible signal abnormalities in the basal ganglia, inferior olivary nuclei, periaqueductal grey matter, and dentate nuclei, with evidence of lactate on magnetic resonance spectroscopy. Molecular analysis of PDH1A revealed a novel hemizygous c.1045G>A mutation, predicting a p.A349T missense mutation. He was treated with thiamine supplementation and, while on this regimen, he experienced several intercurrent febrile episodes without neurological compromise. This case report stresses the importance of performing neuroimaging during acute clinical episodes because brain lesions in PDHC deficiency may be transient and reversible, and false‐negative results may mislead the diagnosis and delay the treatment.